271 related articles for article (PubMed ID: 17992493)
21. Effects of omalizumab on markers of inflammation in patients with allergic asthma.
Holgate S; Smith N; Massanari M; Jimenez P
Allergy; 2009 Dec; 64(12):1728-36. PubMed ID: 19839977
[TBL] [Abstract][Full Text] [Related]
22. [Anti-IgE (Omalizumab): a hope in the treatment of allergic diseases].
Félix Toledo R; Negro Alvarez JM
Rev Clin Esp; 2003 Apr; 203(4):196-8. PubMed ID: 12681204
[No Abstract] [Full Text] [Related]
23. Spotlight on omalizumab in allergic asthma.
Bang LM; Plosker GL
BioDrugs; 2004; 18(6):415-8. PubMed ID: 15571425
[TBL] [Abstract][Full Text] [Related]
24. [Anti-immunoglobulin E, a monoclonal antibody to treat respiratory disorders].
Cabrera-Navarro P
Arch Bronconeumol; 2006 May; 42(5):241-5. PubMed ID: 16740240
[TBL] [Abstract][Full Text] [Related]
25. Anti-IgE monoclonal antibody for the treatment of the asthma and other manifestations related to allergic diseases.
Sarinho E; Cruz AA
J Pediatr (Rio J); 2006 Nov; 82(5 Suppl):S127-32. PubMed ID: 17136288
[TBL] [Abstract][Full Text] [Related]
26. Omalizumab. A review of the new treatment of allergic asthma and seasonal allergic rhinitis.
Félix Toledo R; Negro Alvarez JM; Miralles López JC
Allergol Immunopathol (Madr); 2002; 30(2):94-9. PubMed ID: 11958741
[TBL] [Abstract][Full Text] [Related]
27. Omalizumab: a future innovation for treatment of severe ocular allergy?
Williams PB; Sheppard JD
Expert Opin Biol Ther; 2005 Dec; 5(12):1603-9. PubMed ID: 16318424
[TBL] [Abstract][Full Text] [Related]
28. IgE-Related Chronic Diseases and Anti-IgE-Based Treatments.
Navinés-Ferrer A; Serrano-Candelas E; Molina-Molina GJ; Martín M
J Immunol Res; 2016; 2016():8163803. PubMed ID: 28097159
[TBL] [Abstract][Full Text] [Related]
29. A review of anti-IgE monoclonal antibody (omalizumab) as add on therapy for severe allergic (IgE-mediated) asthma.
D'Amato G; Salzillo A; Piccolo A; D'Amato M; Liccardi G
Ther Clin Risk Manag; 2007 Aug; 3(4):613-9. PubMed ID: 18472983
[TBL] [Abstract][Full Text] [Related]
30. Anti-IgE monoclonal antibody, omalizumab: a new treatment for allergic asthma.
Chung KF
Expert Opin Pharmacother; 2004 Feb; 5(2):439-46. PubMed ID: 14996639
[TBL] [Abstract][Full Text] [Related]
31. Omalizumab: a review of its use in the management of allergic asthma.
Bang LM; Plosker GL
Treat Respir Med; 2004; 3(3):183-99. PubMed ID: 15219177
[TBL] [Abstract][Full Text] [Related]
32. Anti-IgE for the treatment of allergic rhinitis--and eventually nasal polyps?
Verbruggen K; Van Cauwenberge P; Bachert C
Int Arch Allergy Immunol; 2009; 148(2):87-98. PubMed ID: 18799888
[TBL] [Abstract][Full Text] [Related]
33. The role of anti-IgE therapy in combination with allergen specific immunotherapy for seasonal allergic rhinitis.
Stock P; Rolinck-Werninghaus C; Wahn U; Hamelmann E
BioDrugs; 2007; 21(6):403-10. PubMed ID: 18020623
[TBL] [Abstract][Full Text] [Related]
34. Anti-IgE antibodies for the treatment of IgE-mediated allergic diseases.
Chang TW; Wu PC; Hsu CL; Hung AF
Adv Immunol; 2007; 93():63-119. PubMed ID: 17383539
[TBL] [Abstract][Full Text] [Related]
35. Anti-IgE--emerging opportunities for Omalizumab.
Babu KS; Polosa R; Morjaria JB
Expert Opin Biol Ther; 2013 May; 13(5):765-77. PubMed ID: 23517576
[TBL] [Abstract][Full Text] [Related]
36. Anti-IgE therapy: clinical utility beyond asthma.
Casale TB; Stokes J
J Allergy Clin Immunol; 2009 Apr; 123(4):770-1.e1. PubMed ID: 19348915
[No Abstract] [Full Text] [Related]
37. Omalizumab in allergic diseases, a recent review.
Vichyanond P
Asian Pac J Allergy Immunol; 2011 Sep; 29(3):209-19. PubMed ID: 22053590
[TBL] [Abstract][Full Text] [Related]
38. IgE, allergic diseases, and omalizumab.
DuBuske LM
Curr Pharm Des; 2006; 12(30):3929-44. PubMed ID: 17073688
[TBL] [Abstract][Full Text] [Related]
39. Management of asthma with anti-immunoglobulin E: a review of clinical trials of omalizumab.
Nowak D
Respir Med; 2006 Nov; 100(11):1907-17. PubMed ID: 16949266
[TBL] [Abstract][Full Text] [Related]
40. Omalizumab, a novel anti-IgE therapy in allergic disorders.
Babu KS; Arshad SH; Holgate ST
Expert Opin Biol Ther; 2001 Nov; 1(6):1049-58. PubMed ID: 11728235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
